Article · Wikipedia archive · Last revised Jul 4, 2026

Levodopa/benserazide

Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.

Last revised
Jul 4, 2026
Read time
≈ 1 min
Length
120 w
Citations
11
Source
Wikipedia ↗
Levodopa/benserazide
Combination of
LevodopaDopamine agonist
BenserazideDecarboxylase inhibitors
Clinical data
Trade namesProlopa, Madopar, others1
Pregnancy
category
  • AU: B32
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)2
  • CA: ℞-only3
  • UK: POM (Prescription only)4
  • In general: ℞ (Prescription only)
Identifiers
KEGG

Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.234

Medical uses

Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.234

References

References

  1. "Levodopa".
  2. "Madopar Product Information". Medsinfo. 8 July 2019. Retrieved 2 September 2024.
  3. "Prolopa Product information". Health Canada. 25 April 2012. Retrieved 8 January 2023.
  4. "Madopar 100 mg/25 mg Dispersible Tablets - Summary of Product Characteristics (SmPC)". (emc). 8 April 2020. Retrieved 9 January 2023.
External links